Kumar A, Casulo C, Advani RH, Budde E, et al. Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma. J Clin Oncol 2021 Apr 28:JCO2100108. doi: 10.1200/JCO.21.00108.
PMID: 33909449